# Safety and Effectiveness of VYC-12 Hyaluronic Acid Injectable Gel for Treatment of Superficial Cutaneous Depressions

> **NCT02877069** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 134 (actual)

## Conditions studied

- Skin Roughness

## Interventions

- **DEVICE:** VYC-12 HA injectable gel

## Key facts

- **NCT ID:** NCT02877069
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-01
- **Final completion:** 2016-10
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2016-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02877069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02877069, "Safety and Effectiveness of VYC-12 Hyaluronic Acid Injectable Gel for Treatment of Superficial Cutaneous Depressions". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02877069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*